#	Pagina
attuale pagina	/open-h2020/projects/224307/index.html

Opendata, web and dolomites

Dyneelax SIGNED

The world’s first automated laximetry device that replicates daily movements and activities through a dynamic test.

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

Dyneelax project word cloud

Explore the words cloud of the Dyneelax project. It provides you a very rough idea of what is the project "Dyneelax" about.

joints anterior standard ligament patients recovery roadmap healthy healthcare quicker sometimes entirely contact market injuries periods magnetic mission status limited injury replacing waiting core laxity ray clinical first sme genourob motion overcome diagnosing lachman emergency claim knee prioritise acl substitute components imaging cruciate practitioners instrument treatment body function contrast orthopaedist completing transform automated medical fragile invasive quantitative resonance specialists reproducible human point stabilising standardisation confirm diagnosis mechanised gold surveillance ligaments post mri dyneelax carries vital gps scans grant unpredictable laximetry ideal device looseness exams tests scan automation prognosis examinations independent protocol diagnose dynamic wait specialist rotational joint

Project "Dyneelax" data sheet

The following table provides information about the project.

Coordinator	GENOUROB Organization address address: BAT 60 RUE HENRI GERET city: LAVAL postcode: 53000 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	France [FR]
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-1
Funding Scheme	SME-1
Starting year	2019
Duration (year-month-day)	from 2019-07-01 to 2019-11-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	GENOUROB GENOUROB Organization address address: BAT 60 RUE HENRI GERET city: LAVAL postcode: 53000 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (LAVAL)	coordinator	50˙000.00

Map

Project objective

The knee is the largest, and one of the most complex and fragile joints in the human body, and the anterior cruciate ligament (ACL) is one of its core components. The ACL is vital to healthy knee function, stabilising the joint throughout its range of motion. In order to diagnose ACL injuries, the current gold standard is the Lachman’s test, which measures the ‘laxity’ (looseness) of the ligaments in the knee. Often done by hand, this is a reliable process when carried out by a specialist such as an orthopaedist. In contrast, general practitioners (GPs) and other non-specialists require x-ray or magnetic resonance imaging (MRI) exams to confirm their diagnosis. However, waiting periods for mechanised tests in the EU are long, sometimes entirely unpredictable, due to limited equipment availability and the need to prioritise emergency cases.

To overcome this, Genourob has developed Dyneelax, which is the first medical device for automated dynamic laximetry measurement. Dyneelax carries out objective and reproducible Lachman’s tests and rotational exams to assess the laximetry of the ACL. Automation and standardisation of this non-invasive, quantitative testing allows the diagnosis and prognosis of ACL injury and recovery status. It is independent of examinations such as x-ray and MRI scans and it can be used also by non-specialists such as GPs. This means quicker, more effective treatment for better recovery of patients.

At Genourob our mission is to transform the clinical protocol for diagnosing and prognosis of ACL injuries. In this way, GPs would be patients’ main point of contact with the healthcare system, replacing the need to wait for an MRI scan or x-ray for ACL injuries’ treatment. The SME Instrument grant is ideal for completing our product roadmap as it will enable our post-market surveillance to be carried out, to allow us to make the clinical claim that Dyneelax is an effective substitute for MRI scans in diagnosing and evaluating injuries to the ACL

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DYNEELAX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DYNEELAX" are provided by the European Opendata Portal: CORDIS opendata.